Copper
is vital for various life processes, whereas severely toxic
at excess level. Intracellular copper homeostasis is strictly controlled
by a set of transporters and chaperones encoded by the copper homeostasis
genes. Increasing evidence has shown that copper is usually overloaded
in multiple malignancies, including pancreatic cancer, which has an
extremely poor prognosis. Recently, silencing the SLC31A1 gene, which
encodes a major transmembrane copper transporter (CTR1), has been
demonstrated to be an effective means for reducing the malignant degree
of pancreatic cancer by downregulating the cellular copper levels.
Herein, we utilized tetrahedral framework nucleic acids (tFNAs) as
vehicles to overcome the biological barriers for delivering small
molecular RNAs and efficiently transferred two kinds of CTR1 mRNA-targeted
RNA therapeutics, siCTR1 or miR-124, into PANC-1 cells. Both therapeutic
tFNAs, termed t-siCTR1 and t-miR-124, prevented copper intake more
effective than the free RNA therapeutics via efficiently suppressing
the expression of CTR1, thereby significantly attenuating the progression
of PANC-1 cells. In this study, therapeutic tFNAs are constructed
to target metal ion transporters for the first time, which may provide
an effective strategy for future treatment of other metal metabolism
disorders.